NL124473C - - Google Patents

Info

Publication number: NL124473C
Authority: NL; Netherlands

Application number

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1960-07-26

Publication of NL124473C publication Critical patent/NL124473C/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)

NL124473D 1960-07-26 NL124473C (pm)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4529260A	1960-07-26	1960-07-26
US118261A US3176019A (en)	1960-07-26	1961-06-20	Substituted aminobutynyl acetates

Publications (1)

Publication Number	Publication Date
NL124473C true NL124473C (pm)

Family

ID=26722613

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NL267508D NL267508A (pm)	1960-07-26
NL124473D NL124473C (pm)	1960-07-26

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
NL267508D NL267508A (pm)	1960-07-26

Country Status (9)

Country	Link
US (1)	US3176019A (pm)
BE (1)	BE606560A (pm)
CH (1)	CH421078A (pm)
DE (1)	DE1216866B (pm)
DK (1)	DK113854B (pm)
ES (1)	ES269353A1 (pm)
FR (1)	FR1325M (pm)
GB (1)	GB940540A (pm)
NL (2)	NL124473C (pm)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5736577A (en) *	1995-01-31	1998-04-07	Sepracor, Inc.	Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
US3864388A (en) *	1970-12-29	1975-02-04	Sumitomo Chemical Co	Alkynyl esters of {60 -alkoxy-{60 -phenyl alkenoic acid
US5036107A (en) *	1986-06-27	1991-07-30	Marion Merrell Dow Inc.	1,7-substituted heptyn-2-ones and use
US4957941A (en) *	1987-11-16	1990-09-18	United Pharmaceuticals, Inc.	Anti-spasmdoic agents having an acetylenic bond
IL91377A (en) *	1988-09-14	1996-09-12	Nippon Shinyaku Co Ltd	Derivatives of botinylamine glycolate
US5677346A (en) *	1995-01-31	1997-10-14	Sepracor, Inc.	Treating urinary incontinence using (S)-desethyloxybutynin
US5532278A (en) *	1995-01-31	1996-07-02	Sepracor, Inc.	Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
WO1998001125A2 (en) *	1996-07-09	1998-01-15	Sepracor, Inc.	Dextrorotatory isomers of oxybutynin and desethyloxybutynin in the treatment of gastrointestinal hyperactivity
US6140529A (en) *	1998-10-22	2000-10-31	Sepracor Inc.	Synthesis of optically active cyclohexylphenylglycolate esters
US5973182A (en) *	1998-10-22	1999-10-26	Sepracor Inc.	Carbonate Intermediates useful in the preparation of optically active cyclohexylphenylglycolate esters
US7179483B2 (en)	2000-04-26	2007-02-20	Watson Pharmaceuticals, Inc.	Compositions and methods for transdermal oxybutynin therapy
ES2357699T3 (es) *	2000-04-26	2011-04-28	Watson Pharmaceuticals, Inc.	Reducir las experiencias adversas asociada con la terapia de oxibutinina.
ES2315425T3 (es)	2001-10-26	2009-04-01	PHARMACIA & UPJOHN COMPANY LLC	Compuestos de amonio cuaternario y su uso como agentes antimuscarinicos.
DE60230683D1 (de)	2002-07-08	2009-02-12	Ranbaxy Lab Ltd	3,6-disubstituierte azabicyclo-3.1.0 hexan-derivat
HK1079787A1 (zh) *	2002-07-31	2006-04-13	Ranbaxy Laboratories Limited	用作毒蕈碱受体拮抗剂的3，6-二取代的氮杂双环[3．1．0]己烷衍生物
US7410993B2 (en) *	2002-08-09	2008-08-12	Ranbaxy Laboratories Limited	3,6-disubstituted azabicyclo [3.1.0] hexane deriviatives useful as muscarinic receptor antagonists
AU2002326072A1 (en) *	2002-08-23	2004-03-11	Ranbaxy Laboratories Limited	Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists
TW200412945A (en)	2002-10-25	2004-08-01	Upjohn Co	Quaternary ammonium compounds
WO2004052857A1 (en)	2002-12-10	2004-06-24	Ranbaxy Laboratories Limited	3,6-disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists
DE60225195T2 (de) *	2002-12-23	2009-02-26	Ranbaxy Laboratories, Ltd.	Flavaxat-derivate als muscarin-rezeptor antagonisten
WO2004056767A1 (en) *	2002-12-23	2004-07-08	Ranbaxy Laboratories Limited	1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists
US7488748B2 (en)	2003-01-28	2009-02-10	Ranbaxy Laboratories Limited	3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
WO2004089898A1 (en) *	2003-04-09	2004-10-21	Ranbaxy Laboratories Limited	Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
US7560479B2 (en)	2003-04-10	2009-07-14	Ranbaxy Laboratories Limited	3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
CA2521788A1 (en) *	2003-04-10	2004-10-21	Ranbaxy Laboratories Limited	Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
US20070021487A1 (en) *	2003-04-11	2007-01-25	Mohammad Salman	Azabicyclo derivatives as muscarinic receptor antagonists
ATE419246T1 (de) *	2004-06-16	2009-01-15	Ranbaxy Lab Ltd	Als antagonisten des muscarinrezeptors geeignete xanthinderivate
WO2006018708A2 (en) *	2004-08-19	2006-02-23	Ranbaxy Laboratories Limited	Pyrrolidine derivatives as muscarinic receptor antagonists
EP1794161A2 (en) *	2004-09-24	2007-06-13	Ranbaxy Laboratories Limited	Muscarinic receptor antagonists
US20090105221A1 (en) *	2004-09-29	2009-04-23	Ranbaxy Laboratories Limited	Muscarinic receptor antagonists
US20100016400A1 (en) *	2004-11-19	2010-01-21	Naresh Kumar	Azabicyclic muscarinic receptor antagonists
EP1828126A1 (en) *	2004-12-15	2007-09-05	Ranbaxy Laboratories Limited	Acid addition salts of muscarinic receptor antagonists
WO2006117754A1 (en) *	2005-05-03	2006-11-09	Ranbaxy Laboratories Limited	3,6-disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists
JP2009512676A (ja)	2005-10-19	2009-03-26	ランバクシーラボラトリーズリミテッド	ムスカリン性受容体アンタゴニストの医薬組成物
US20090010923A1 (en) *	2007-04-24	2009-01-08	University Of Maryland, Baltimore	Treatment of cancer with anti-muscarinic receptor agents
WO2009122429A2 (en) *	2008-02-04	2009-10-08	Matrix Laboratories Limited	Crystalline oxybutynin and process for preparing the same
WO2011137054A1 (en)	2010-04-30	2011-11-03	Merck Sharp & Dohme Corp.	Novel beta 3 adrenergic receptor agonists
US9907767B2 (en)	2010-08-03	2018-03-06	Velicept Therapeutics, Inc.	Pharmaceutical compositions and the treatment of overactive bladder
NZ607485A (en)	2010-08-03	2015-04-24	Altherx Inc	Combinations of beta - 3 adrenergic receptor agonists and muscarinic receptor antagonists for treating overactive bladder
HK1204966A1 (en)	2012-02-09	2015-12-11	Velicept Therapeutics, Inc.	Combination of muscarinic receptor antagonists and beta- 3 adrenoceptor agonists for treating overactive bladder
US9956194B2 (en)	2014-12-03	2018-05-01	Velicept Therapeutics, Inc.	Compositions and methods of using modified release solabegron for lower urinary tract symptoms
PL3365321T3 (pl)	2015-10-23	2024-03-25	B3Ar Therapeutics, Inc.	Jon obojnaczy solabegronu i jego zastosowania
HRP20241412T1 (hr)	2018-01-30	2024-12-20	Apnimed, Inc. (Delaware)	Postupci i pripravci namijenjeni liječenju apneje u snu ili običnog hrkanja

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE895595C (de) *	1943-09-29	1953-11-05	Basf Ag	Verfahren zur Herstellung von Aminoalkinolen
DE1003209B (de) *	1953-03-24	1957-02-28	Basf Ag	Verfahren zur Herstellung spasmolytisch wirksamer basischer Carbinole
US2867619A (en) *	1956-11-05	1959-01-06	Lakeside Lab Inc	Aminoalkynyl-n-alkylpiperidine carboxylates
DE1083254B (de) *	1957-04-01	1960-06-15	Lakeside Lab In	Verfahren zur Herstellung von blutdrucksenkenden N-disubstituierten Diaminoalkinen, deren Saeureadditionssalzen oder quaternaeren Ammoniumsalzen
DE1100617B (de) *	1959-10-22	1961-03-02	Basf Ag	Verfahren zur Herstellung von 1-Dialkylamino-4-hydroxy-acetylenen-(2)

0
- NL NL267508D patent/NL267508A/xx unknown
- NL NL124473D patent/NL124473C/xx active
1961
- 1961-06-20 US US118261A patent/US3176019A/en not_active Expired - Lifetime
- 1961-07-19 DE DEM49737A patent/DE1216866B/de active Pending
- 1961-07-20 CH CH856161A patent/CH421078A/de unknown
- 1961-07-20 FR FR868440A patent/FR1325M/fr active Active
- 1961-07-24 ES ES0269353A patent/ES269353A1/es not_active Expired
- 1961-07-25 GB GB26864/61A patent/GB940540A/en not_active Expired
- 1961-07-25 DK DK304861AA patent/DK113854B/da unknown
- 1961-07-26 BE BE606560A patent/BE606560A/fr unknown

Also Published As

Publication number	Publication date
GB940540A (en)	1963-10-30
FR1325M (fr)	1962-05-21
DE1216866B (de)	1966-05-18
US3176019A (en)	1965-03-30
NL267508A (pm)
CH421078A (de)	1966-09-30
BE606560A (fr)	1962-01-26
DK113854B (da)	1969-05-05
ES269353A1 (es)	1961-11-16

Publication	Publication Date	Title
JPS3915861B1 (pm)	1964-08-06
FR1228281A (pm)	1960-08-29
FR873M (pm)	1960-10-16
DE1160947C2 (pm)	1964-07-30
FI45818B (pm)	1972-06-30
BE609567A (pm)
BE647713A (pm)	1964-11-09
BE601054A (pm)
BE601009A (pm)
BE600910A (pm)
BE600885A (pm)
BE600656A (pm)
NL124473C (pm)
BE599939A (pm)	1961-08-07
BE599934A (pm)
BE602896A (pm)
BE602875A (pm)
BE599075A (pm)
DD26119A3 (pm)	1963-10-10
BE602392A (pm)
BE599759A (pm)
BE599556A (pm)
BE599397A (pm)
BE594367A (pm)
BE602865A (pm)